The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him. Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try and save him from the fatal condition. Although little is known about how he died, his death occurred during one of the first studies to test a gene editing treatment built for one person. It's raising questions about the overall prospect of such therapies, which have buoyed hopes among many families facing rare and devastating diseases. “This whole notion that
Hence then, the article about death in crispr gene therapy study sparks search for answers was published today ( ) and is available onChron ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Death in CRISPR gene therapy study sparks search for answers )